drugset / Trial / NCT01149538

Postnatal Choline Supplementation in Children With Prenatal Alcohol Exposure

NCT01149538

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine if choline bitartrate can be administered daily to children with prenatal alcohol exposure, ages 2.5 to 5, as a potential treatment for brain development and cognitive functioning.

Timeline

Start
2010-07
Primary completion
2014-09
Completion
2014-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Choline Other / unclassified 500 mg Oral